iProstate
iProstate, licence 80089118: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- NuEra Nutraceutical Inc.
- NPN or DIN-HM
- 80089118
- Status
- Active licence
- Licence date
- 8 November 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 45 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 45 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cucurbita pepo Source : Fruit | 75.0 mg | Not calculated |
| Prunus africana Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 750.0 mg Potency : 12.0 % Phytosterols | 75.0 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 500.0 mg | 50.0 mg | Not calculated |
| Allium sativum Source : Bulbe Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1000.0 mg Potency : 1.3 % Alliin | 100.0 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 25.0 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 400.0 mg | 40.0 mg | Not calculated |
| Ganoderma lucidum Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 750.0 mg | 75.0 mg | Not calculated |
| Juniperus communis Source : Fruit | 5.0 mg | Not calculated |
| Zinc | 22.5 mg | 45,000 µg |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1700.0 mg Potency : 45.0 % Fatty acids | 170.0 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone | 75.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Provides antioxidants. Saw palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist and/or worsen. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. Consult a health care practitioner prior to use if you are taking blood thinners, anti-platelet medication or protease inhibitors. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction, or if you have stomach ulcers or excess stomach acid.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have a kidney disorder.
Source
Official Health Canada record, licence 80089118
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.